Related references
Note: Only part of the references are listed.Dual targeting of MEK and PI3K effectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with different genetic backgrounds
Ge-Ping Qu et al.
BMC PULMONARY MEDICINE (2021)
Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer
Chennianci Zhu et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
Emilie Picard et al.
FRONTIERS IN IMMUNOLOGY (2020)
A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma
Feng Xu et al.
ONCOIMMUNOLOGY (2020)
Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing
Xiaoyun Zhou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy
Wenfeng Fang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Comparison of Annotation Services for Next-Generation Sequencing in a Large-Scale Precision Oncology Program
Evangelia Katsoulakis et al.
JCO PRECISION ONCOLOGY (2020)
Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer
Shiwang Wen et al.
ONCOLOGIST (2019)
Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an update
Helene Blons et al.
JOURNAL OF THORACIC DISEASE (2019)
A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)
Kiichiro Ninomiya et al.
CHEST (2019)
DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC
Sehhoon Park et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies
Jingyu Cao et al.
ONCOLOGIST (2019)
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou et al.
CANCER RESEARCH (2019)
Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions
Vitor H. Teixeira et al.
NATURE MEDICINE (2019)
Mutational Profiling of Non-Small-Cell Lung Cancer Resistant to Osimertinib Using Next-Generation Sequencing in Chinese Patients
Keke Nie et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA
Nikola P. Konstandin et al.
BLOOD ADVANCES (2018)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Corey J. Langer et al.
LANCET ONCOLOGY (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mechanisms of resistance to EGFR-targeted drugs: lung cancer
Floriana Morgillo et al.
ESMO OPEN (2016)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
I-TASSER server: new development for protein structure and function predictions
Jianyi Yang et al.
NUCLEIC ACIDS RESEARCH (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
A Genomics-Based Classification of Human Lung Tumors
Danila Seidel et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
Pablo Cingolani et al.
FLY (2012)
The transcriptional landscape and mutational profile of lung adenocarcinoma
Jeong-Sun Seo et al.
GENOME RESEARCH (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
Devika Gajria et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Share Paper
